Jonathan S. Serody

21.4k total citations · 3 hit papers
184 papers, 9.0k citations indexed

About

Jonathan S. Serody is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Jonathan S. Serody has authored 184 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Immunology, 85 papers in Oncology and 69 papers in Hematology. Recurrent topics in Jonathan S. Serody's work include Hematopoietic Stem Cell Transplantation (59 papers), Immunotherapy and Immune Responses (54 papers) and Immune Cell Function and Interaction (47 papers). Jonathan S. Serody is often cited by papers focused on Hematopoietic Stem Cell Transplantation (59 papers), Immunotherapy and Immune Responses (54 papers) and Immune Cell Function and Interaction (47 papers). Jonathan S. Serody collaborates with scholars based in United States, Germany and China. Jonathan S. Serody's co-authors include Bruce R. Blazar, Benjamin G. Vincent, Angela Panoskaltsis‐Mortari, Charles M. Perou, Karen P. McKinnon, Joel S. Parker, Christian Wysocki, James M. Coghill, Christof C. Smith and Shengjie Chai and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jonathan S. Serody

179 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy

2017 590 citations Karen P. McKinnon, Shengjie Chai et al. profile →
B Cell Function in the Tumor Microenvironment

2022 193 citations Benjamin G. Vincent, Jonathan S. Serody et al. profile →
Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment

2024 62 citations Jonathan S. Serody et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan S. Serody United States	53	5.4k	3.3k	2.3k	2.1k	924	184	9.0k
Robert Zeiser Germany	56	5.2k 1.0×	2.8k 0.9×	4.5k 1.9×	2.8k 1.4×	805 0.9×	287	11.4k
Matthias Edinger Germany	35	5.7k 1.0×	2.2k 0.7×	2.3k 1.0×	2.2k 1.1×	347 0.4×	114	8.9k
Richard Childs United States	57	4.6k 0.8×	3.8k 1.1×	4.6k 2.0×	2.3k 1.1×	494 0.5×	273	10.7k
Håkan Mellstedt Sweden	51	5.4k 1.0×	3.5k 1.1×	1.5k 0.6×	2.7k 1.3×	536 0.6×	298	9.9k
Larry W. Kwak United States	61	6.2k 1.2×	4.9k 1.5×	1.5k 0.6×	3.9k 1.9×	718 0.8×	319	12.6k
Claudio Tripodo Italy	55	4.6k 0.9×	2.8k 0.9×	830 0.4×	3.0k 1.5×	843 0.9×	245	10.5k
Dominic W. Chung United States	47	2.4k 0.4×	1.8k 0.6×	3.2k 1.3×	1.7k 0.8×	1.4k 1.5×	101	8.1k
Marion Subklewe Germany	42	3.9k 0.7×	3.8k 1.2×	1.5k 0.7×	2.6k 1.3×	328 0.4×	167	8.4k
Wyndham H. Wilson United States	66	4.8k 0.9×	9.0k 2.7×	1.2k 0.5×	4.0k 1.9×	1.2k 1.3×	329	17.6k
Steven L. Allen United States	45	4.5k 0.8×	1.9k 0.6×	2.5k 1.1×	3.2k 1.6×	527 0.6×	225	11.4k

Countries citing papers authored by Jonathan S. Serody

Since Specialization

Citations

This map shows the geographic impact of Jonathan S. Serody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Serody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Serody more than expected).

Fields of papers citing papers by Jonathan S. Serody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Serody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Serody. The network helps show where Jonathan S. Serody may publish in the future.

Co-authorship network of co-authors of Jonathan S. Serody

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan S. Serody. A scholar is included among the top collaborators of Jonathan S. Serody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan S. Serody. Jonathan S. Serody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruce, Danny, Sonia J. Laurie, Yan Xing, et al.. (2025). A simple and efficient method for the robust expansion of human ILC2s to prevent acute GVHD. Blood Advances. 9(19). 4951–4962. 1 indexed citations

Serody, Jonathan S., Paul M. Armistead, Gianpietro Dotti, et al.. (2025). Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults. Open Forum Infectious Diseases. 12(9). ofaf541–ofaf541.

Laurie, Sonia J., Danny Bruce, Hemamalini Bommiasamy, et al.. (2024). Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation. Nature Communications. 15(1). 6000–6000. 4 indexed citations

Yazdimamaghani, Mostafa, Chaemin Lim, Duhyeong Hwang, et al.. (2024). Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy. Biomaterials. 312. 122750–122750. 13 indexed citations

Grover, Natalie S., Anastasia Ivanova, Dominic Moore, et al.. (2022). CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/ Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma. Transplantation and Cellular Therapy. 28(3). S54–S55. 2 indexed citations

Riches, Marcie, Thomas C. Shea, Anastasia Ivanova, et al.. (2021). Infusion of CD30 CAR T Cells Is Safe and Effective As Consolidation Following Autologous Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 27(3). S65–S66. 3 indexed citations

Smith, Christof C., Shengjie Chai, Samuel Lee, et al.. (2019). Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes. Cancer Immunology Research. 7(10). 1591–1604. 47 indexed citations

Thangavelu, Govindarajan, Yu‐Chi Lee, Michaël Loschi, et al.. (2019). Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality. The Journal of Immunology. 202(9). 2795–2805. 11 indexed citations

Davis, Jessica, Anastasia Ivanova, Yunro Chung, et al.. (2018). Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(2). 391–397. 8 indexed citations

10.

Zeidner, Joshua F., Benjamin G. Vincent, Anastasia Ivanova, et al.. (2017). Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML). Blood. 130. 1349–1349. 10 indexed citations

11.

Bruce, Danny, Heather E. Stefanski, Benjamin G. Vincent, et al.. (2017). Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. Journal of Clinical Investigation. 127(5). 1813–1825. 85 indexed citations

12.

Xing, Yan, Heather E. Stefanski, Danny Bruce, et al.. (2017). A Novel Process for the Expansion of Functional Human ILC2 Cells for GCHD Prevention. Blood. 130. 4432–4432. 5 indexed citations

13.

Montfort, Anne, Oliver M.T. Pearce, Eleni Maniati, et al.. (2016). A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases. Clinical Cancer Research. 23(1). 250–262. 172 indexed citations

14.

Koehn, Brent H., Petya Apostolova, Jessica M. Haverkamp, et al.. (2015). GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 126(13). 1621–1628. 91 indexed citations

15.

Iglesia, Michael D., Benjamin G. Vincent, Joel S. Parker, et al.. (2014). Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer. Clinical Cancer Research. 20(14). 3818–3829. 194 indexed citations

16.

Wu, Qing, et al.. (2013). C-C Chemokine Receptor 5 on Pulmonary Mesenchymal Cells Promotes Experimental Metastasis via the Induction of Erythroid Differentiation Regulator 1. Molecular Cancer Research. 12(2). 274–282. 8 indexed citations

17.

Deventer, Hendrik W. van, Joseph E. Burgents, Qing Wu, et al.. (2010). The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells. Cancer Research. 70(24). 10161–10169. 135 indexed citations

18.

Burgents, Joseph E., Timothy P. Moran, Michelle L. West, et al.. (2010). The Immunosuppressive Tumor Environment Is the Major Impediment to Successful Therapeutic Vaccination in Neu Transgenic Mice. Journal of Immunotherapy. 33(5). 482–491. 12 indexed citations

19.

Deventer, Hendrik W. van, Qing Wu, Dan T. Bergstralh, et al.. (2008). C-C Chemokine Receptor 5 on Pulmonary Fibrocytes Facilitates Migration and Promotes Metastasis via Matrix Metalloproteinase 9. American Journal Of Pathology. 173(1). 253–264. 48 indexed citations

20.

Kuhns, Jennifer J., Susan E. Burkett, John D. Powderly, et al.. (2003). Host Absence of CCR5 Potentiates Dendritic Cell Vaccination. The Journal of Immunology. 170(8). 4201–4208. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact